Skip to content
Disclosery

ENAVATE SCIENCES GP, LLC: CAMP position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ENAVATE SCIENCES GP, LLC on CAMP, newest first. How the timeline and the estimate are built.

ENAVATE SCIENCES GP, LLC held 1,425,541 CAMP shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 1,425,541 shares
    Change vs previous 13F -765,379 shares

    1.8% of the 13F portfolio, value $6,229,614.

    13F-HR 0001953107-26-000012 filed by ENAVATE SCIENCES GP, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 2,190,920 shares
    Change vs previous 13F -844,905 shares

    2.75% of the 13F portfolio, value $9,661,957.

    13F-HR 0001953107-26-000008 filed by ENAVATE SCIENCES GP, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 3,035,825 shares
    Change vs previous 13F -749,977 shares

    3.67% of the 13F portfolio, value $18,609,607.

    13F-HR 0001953107-26-000003 filed by ENAVATE SCIENCES GP, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 3,785,802 shares
    Change vs previous 13F 0 shares

    3.47% of the 13F portfolio, value $11,357,406.

    13F-HR 0001953107-25-000014 filed by ENAVATE SCIENCES GP, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 3,785,802 shares
    Change vs previous 13F 0 shares

    3.11% of the 13F portfolio, value $5,489,413.

    13F-HR 0001415889-25-021852 filed by ENAVATE SCIENCES GP, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 3,785,802 shares
    Change vs previous 13F 0 shares

    11.41% of the 13F portfolio, value $15,143,208.

    13F-HR 0001415889-25-013132 filed by ENAVATE SCIENCES GP, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 3,785,802 shares
    Change vs previous 13F not available

    14.19% of the 13F portfolio, value $19,761,886.

    13F-HR 0001104659-25-014094 filed by ENAVATE SCIENCES GP, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).